Vanguard Personalized Indexing Management, LLC Halozyme Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $4.59 Billion
- Q1 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 18,248 shares of HALO stock, worth $940,866. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,248
Previous 20,050
8.99%
Holding current value
$940,866
Previous $741,000
0.13%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding HALO
# of Institutions
442Shares Held
122MCall Options Held
216KPut Options Held
140K-
Black Rock Inc. New York, NY18.2MShares$941 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$673 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$334 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.12MShares$212 Million3.73% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$195 Million0.24% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.18B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...